Increased cell surface fas expression is necessary and sufficient to sensitize lung fibroblasts to fas ligation-induced apoptosis: Implications for fibroblast accumulation in idiopathic pulmonary fibrosis

Journal of Immunology

Volumn 187, Issue 1, 2011, Pages 527-537

  Wynes, Murry W ^a,b   Edelman, Benjamin L ^a   Kostyk, Amanda G ^a   Edwards, Michael G ^b   Coldren, Christopher ^b   Groshong, Steve D ^a,b   Cosgrove, Gregory P ^a,b   Redente, Elizabeth F ^a   Bamberg, Alison ^a,b   Brown, Kevin K ^a,b   Reisdorph, Nichole ^b   Keith, Rebecca C ^a,b   Frankel, Stephen K ^a,b   Riches, David W H ^a,b  

^a DEPARTMENT OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 12; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA;

ADENOVIRUS; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BIOACCUMULATION; CELL STIMULATION; CELL SURFACE; CONTROLLED STUDY; FIBROSING ALVEOLITIS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG FIBROBLAST; LUNG PARENCHYMA; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SENSITIZATION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CELL LINE; CELL LINE, TRANSFORMED; CELLS, CULTURED; FAS LIGAND PROTEIN; FIBROBLASTS; GENE EXPRESSION PROFILING; HUMANS; LONGITUDINAL STUDIES; LUNG; MICE; MICE, KNOCKOUT; PROSPECTIVE STUDIES; PULMONARY FIBROSIS; UP-REGULATION;

EID: 79960413985     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100447     Document Type: Article

References (62)

1. Selman, M., T. E. King, and A. Pardo; American Thoracic Society; European Respiratory Society; American College of Chest Physicians. 2001. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann. Intern. Med. 134: 136-151.
2. Katzenstein, A. L., and J. L. Myers. 1998. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am. J. Respir. Crit. Care Med. 157: 1301-1315.
3. Myers, J. L., and A. L. Katzenstein. 1988. Epithelial necrosis and alveolar collapse in the pathogenesis of usual interstitial pneumonia. Chest 94: 1309-1311.
4. Hashimoto, N., H. Jin, T. Liu, S. W. Chensue, and S. H. Phan. 2004. Bone marrow-derived progenitor cells in pulmonary fibrosis. J. Clin. Invest. 113: 243-252.
5. Willis, B. C., J. M. Liebler, K. Luby-Phelps, A. G. Nicholson, E. D. Crandall, R. M. du Bois, and Z. Borok. 2005. Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am. J. Pathol. 166: 1321-1332.
6. Wu, Z., L. Yang, L. Cai, M. Zhang, X. Cheng, X. Yang, and J. Xu. 2007. Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an alpha-smooth muscle actin-Cre transgenic mouse. Respir. Res. 8: 1.
7. Kim, K. K., M. C. Kugler, P. J. Wolters, L. Robillard, M. G. Galvez, A. N. Brumwell, D. Sheppard, and H. A. Chapman. 2006. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc. Natl. Acad. Sci. USA 103: 13180-13185.
8. Tanjore, H., X. C. Xu, V. V. Polosukhin, A. L. Degryse, B. Li, W. Han, T. P. Sherrill, D. Plieth, E. G. Neilson, T. S. Blackwell, and W. E. Lawson. 2009. Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis. Am. J. Respir. Crit. Care Med. 180: 657-665.
9. Tomasek, J. J., G. Gabbiani, B. Hinz, C. Chaponnier, and R. A. Brown. 2002. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat. Rev. Mol. Cell Biol. 3: 349-363.
10. Zhang, K., M. D. Rekhter, D. Gordon, and S. H. Phan. 1994. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. Am. J. Pathol. 145: 114-125.
11. Gabbiani, G. 2003. The myofibroblast in wound healing and fibrocontractive diseases. J. Pathol. 200: 500-503. (Pubitemid 36818250)
12. Lappi-Blanco, E., Y. Soini, and P. Pääkkö. 1999. Apoptotic activity is increased in the newly formed fibromyxoid connective tissue in bronchiolitis obliterans organizing pneumonia. Lung 177: 367-376.
13. Cha, S. I., S. D. Groshong, S. K. Frankel, B. L. Edelman, G. P. Cosgrove, J. L. Terry-Powers, L. K. Remigio, D. Curran-Everett, K. K. Brown, C. D. Cool, and D.W. Riches. 2010. Compartmentalized expression of c-FLIP in lung tissues of patients with idiopathic pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 42: 140-148.
14. Maher, T. M., I. C. Evans, S. E. Bottoms, P. F. Mercer, A. J. Thorley, A. G. Nicholson, G. J. Laurent, T. D. Tetley, R. C. Chambers, and R. J. McAnulty. 2010. Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 182: 73-82.
15. Zhang, H.-Y., and S. H. Phan. 1999. Inhibition of myofibroblast apoptosis by transforming growth factor b(1). Am. J. Respir. Cell Mol. Biol. 21: 658-665.
16. Oakley, F., V. Teoh, A. S. G. Ching, R. Bataller, J. Colmenero, J. R. Jonsson, A. G. Eliopoulos, M. R. Watson, D. Manas, and D. A. Mann. 2009. Angiotensin II activates I kappaB kinase phosphorylation of RelA at Ser 536 to promote myofibroblast survival and liver fibrosis. Gastroenterology 136: 2334-2344.
17. Lavrik, I. N., A. Golks, D. Riess, M. Bentele, R. Eils, and P. H. Krammer. 2007. Analysis of CD95 threshold signaling: triggering of CD95 (FAS/APO-1) at low concentrations primarily results in survival signaling. J. Biol. Chem. 282: 13664-13671.
18. Tran, S. E., T. H. Holmstrom, M. Ahonen, V. M. Kahari, and J. E. Eriksson. 2001. MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors. J. Biol. Chem. 276: 16484-16490.
19. Zuliani, C., S. Kleber, S. Klussmann, T. Wenger, M. Kenzelmann, N. Schreglmann, A. Martinez, J. A. del Rio, E. Soriano, P. Vodrazka, et al. 2006. Control of neuronal branching by the death receptor CD95 (Fas/Apo-1). Cell Death Differ. 13: 31-40.
20. Frankel, S. K., G. P. Cosgrove, S. I. Cha, C. D. Cool, M. W. Wynes, B. L. Edelman, K. K. Brown, and D. W. Riches. 2006. TNF-alpha sensitizes normal and fibrotic human lung fibroblasts to Fas-induced apoptosis. Am. J. Respir. Cell Mol. Biol. 34: 293-304.
21. Huang, S. K., E. S. White, S. H. Wettlaufer, H. Grifka, C. M. Hogaboam, V. J. Thannickal, J. C. Horowitz, and M. Peters-Golden. 2009. Prostaglandin E (2) induces fibroblast apoptosis by modulating multiple survival pathways. FASEB J. 23: 4317-4326.
22. Golan-Gerstl, R., S. B. Wallach-Dayan, G. Amir, and R. Breuer. 2007. Epithelial cell apoptosis by fas ligand-positive myofibroblasts in lung fibrosis. Am. J. Respir. Cell Mol. Biol. 36: 270-275.
23. Wallach-Dayan, S. B., R. Golan-Gerstl, and R. Breuer. 2007. Evasion of myofibroblasts from immune surveillance: a mechanism for tissue fibrosis. Proc. Natl. Acad. Sci. USA 104: 20460-20465.
24. Martinez, J. A., T. E. King, Jr., K. Brown, C. A. Jennings, L. Borish, R. L. Mortenson, T. Z. Khan, T. W. Bost, and D. W. Riches. 1997. Increased expression of the interleukin-10 gene by alveolar macrophages in interstitial lung disease. Am. J. Physiol. 273: L676-L683.
25. Tzortzaki, E. G., K. M. Antoniou, M. I. Zervou, I. Lambiri, A. Koutsopoulos, N. Tzanakis, M. Plataki, G. Maltezakis, D. Bouros, and N. M. Siafakas. 2007. Effects of antifibrotic agents on TGF-beta1, CTGF and IFN-gamma expression in patients with idiopathic pulmonary fibrosis. Respir. Med. 101: 1821-1829.
26. Borok, Z., A. Gillissen, R. Buhl, R. F. Hoyt, R. C. Hubbard, T. Ozaki, S. I. Rennard, and R. G. Crystal. 1991. Augmentation of functional prostaglandin E levels on the respiratory epithelial surface by aerosol administration of prostaglandin E. Am. Rev. Respir. Dis. 144: 1080-1084.
27. American Thoracic Society,European Respiratory Society. 2000. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am. J. Respir. Crit. Care Med. 161: 646-664.
28. American Thoracic SocietyEuropean Respiratory Society. 2002. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am. J. Respir. Crit. Care Med. 165: 277-304.
29. Wynes, M. W., and D. W. Riches. 2003. Induction of macrophage insulin-like growth factor-I expression by the Th2 cytokines IL-4 and IL-13. J. Immunol. 171: 3550-3559.
30. Kostyk, A. G., K. M. Dahl, M. W. Wynes, L. A. Whittaker, D. J. Weiss, R. Loi, and D. W. Riches. 2006. Regulation of chemokine expression by NaCl occurs independently of cystic fibrosis transmembrane conductance regulator in macrophages. Am. J. Pathol. 169: 12-20.
31. Chan, E. D., B. W. Winston, M. B. Jarpe, M. W. Wynes, and D. W. Riches. 1997. Preferential activation of the p46 isoform of JNK/SAPK in mouse macrophages by TNF alpha. Proc. Natl. Acad. Sci. USA 94: 13169-13174.
32. Tumor Analysis Best Practices Working Group. 2004. Expression profiling - best practices for data generation and interpretation in clinical trials. Nat. Rev. Genet. 5: 229-237.
33. Bennett, M., K. Macdonald, S. W. Chan, J. P. Luzio, R. Simari, and P. Weissberg. 1998. Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. Science 282: 290-293. (Pubitemid 28487200)
34. Ivanov, V. N., P. Lopez Bergami, G. Maulit, T. A. Sato, D. Sassoon, and Z. Ronai. 2003. FAP-1 association with Fas (Apo-1) inhibits Fas expression on the cell surface. Mol. Cell. Biol. 23: 3623-3635.
35. MacEwan, D. J. 2002. TNF ligands and receptors - a matter of life and death. Br. J. Pharmacol. 135: 855-875.
36. Lasham, A., E. Lindridge, F. Rudert, R. Onrust, and J. Watson. 2000. Regulation of the human fas promoter by YB-1, Puralpha and AP-1 transcription factors. Gene 252: 1-13. (Pubitemid 30618808)
37. Chan, H., D. P. Bartos, and L. B. Owen-Schaub. 1999. Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 recruitment. Mol. Cell. Biol. 19: 2098-2108.
38. Zalcenstein, A., P. Stambolsky, L. Weisz, M. Müller, D. Wallach, T. M. Goncharov, P. H. Krammer, V. Rotter, and M. Oren. 2003. Mutant p53 gain of function: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutants. Oncogene 22: 5667-5676. (Pubitemid 37102703)
39. Liu, W. H., and L. S. Chang. 2009. Arachidonic acid induces Fas and FasL upregulation in human leukemia U937 cells via Ca2+/ROS-mediated suppression of ERK/c-Fos pathway and activation of p38 MAPK/ATF-2 pathway. Toxicol. Lett. 191: 140-148.
40. Shen, Y., R. Li, and K. Shiosaki. 1997. Inhibition of p75 tumor necrosis factor receptor by antisense oligonucleotides increases hypoxic injury and beta-amyloid toxicity in human neuronal cell line. J. Biol. Chem. 272: 3550-3553.
41. Mukhopadhyay, A., J. Suttles, R. D. Stout, and B. B. Aggarwal. 2001. Genetic deletion of the tumor necrosis factor receptor p60 or p80 abrogates ligand-mediated activation of nuclear factor-kappa B and of mitogen-activated protein kinases in macrophages. J. Biol. Chem. 276: 31906-31912.
42. Song, E., S. K. Lee, J. Wang, N. Ince, N. Ouyang, J. Min, J. Chen, P. Shankar, and J. Lieberman. 2003. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat. Med. 9: 347-351.
43. Wesche-Soldato, D. E., C. S. Chung, J. Lomas-Neira, L. A. Doughty, S. H. Gregory, and A. Ayala. 2005. In vivo delivery of caspase-8 or Fas siRNA improves the survival of septic mice. Blood 106: 2295-2301.
44. Fiering, S., J. P. Northrop, G. P. Nolan, P. S. Mattila, G. R. Crabtree, and L. A. Herzenberg. 1990. Single cell assay of a transcription factor reveals a threshold in transcription activated by signals emanating from the T-cell antigen receptor. Genes Dev. 4: 1823-1834.
45. Carter, R. H., and D. T. Fearon. 1992. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256: 105-107.
46. Moodley, Y. P., P. Caterina, A. K. Scaffidi, N. L. Misso, J. M. Papadimitriou, R. J. McAnulty, G. J. Laurent, P. J. Thompson, and D. A. Knight. 2004. Comparison of the morphological and biochemical changes in normal human lung fibroblasts and fibroblasts derived from lungs of patients with idiopathic pulmonary fibrosis during FasL-induced apoptosis. J. Pathol. 202: 486-495.
47. Kazufumi, M., N. Sonoko, K. Masanori, I. Takateru, and O. Akira. 1997. Expression of bcl-2 protein and APO-1 (Fas antigen) in the lung tissue from patients with idiopathic pulmonary fibrosis. Microsc. Res. Tech. 38: 480-487.
48. Wilborn, J., L. J. Crofford, M. D. Burdick, S. L. Kunkel, R. M. Strieter, and M. Peters-Golden. 1995. Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2. J. Clin. Invest. 95: 1861-1868.
49. Bauman, K. A., S. H. Wettlaufer, K. Okunishi, K. M. Vannella, J. S. Stoolman, S. K. Huang, A. J. Courey, E. S. White, C. M. Hogaboam, R. H. Simon, et al. 2010. The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice. J. Clin. Invest. 120: 1950-1960.
50. Gochuico, B. R., K. M. Miranda, E. M. Hessel, J. J. De Bie, A. J. Van Oosterhout, W. W. Cruikshank, and A. Fine. 1998. Airway epithelial Fas ligand expression: potential role in modulating bronchial inflammation. Am. J. Physiol. 274: L444-L449.
51. Hamann, K. J., D. R. Dorscheid, F. D. Ko, A. E. Conforti, A. I. Sperling, K. F. Rabe, and S. R. White. 1998. Expression of Fas (CD95) and FasL (CD95L) in human airway epithelium. Am. J. Respir. Cell Mol. Biol. 19: 537-542.
52. Kuwano, K., H. Miyazaki, N. Hagimoto, M. Kawasaki, M. Fujita, R. Kunitake, Y. Kaneko, and N. Hara. 1999. The involvement of Fas-Fas ligand pathway in fibrosing lung diseases. Am. J. Respir. Cell Mol. Biol. 20: 53-60.
53. Kuwano, K., M. Kawasaki, T. Maeyama, N. Hagimoto, N. Nakamura, K. Shirakawa, and N. Hara. 2000. Soluble form of fas and fas ligand in BAL fluid from patients with pulmonary fibrosis and bronchiolitis obliterans organizing pneumonia. Chest 118: 451-458. (Pubitemid 30637815)
54. Kiener, P. A., P. M. Davis, G. C. Starling, C. Mehlin, S. J. Klebanoff, J. A. Ledbetter, and W. C. Liles. 1997. Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages. J. Exp. Med. 185: 1511-1516.
55. Furuke, K., M. Shiraishi, H. S. Mostowski, and E. T. Bloom. 1999. Fas ligand induction in human NK cells is regulated by redox through a calcineurin-nuclear factors of activated T cell-dependent pathway. J. Immunol. 162: 1988-1993.
56. Uhal, B. D., I. Joshi, W. F. Hughes, C. Ramos, A. Pardo, and M. Selman. 1998. Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung. Am. J. Physiol. 275: L1192-L1199.
57. Shinohara, H., H. Yagita, Y. Ikawa, and N. Oyaizu. 2000. Fas drives cell cycle progression in glioma cells via extracellular signal-regulated kinase activation. Cancer Res. 60: 1766-1772. (Pubitemid 30183454)
58. Wisniewski, P., A. Ellert-Miklaszewska, A. Kwiatkowska, and B. Kaminska. 2010. Non-apoptotic Fas signaling regulates invasiveness of glioma cells and modulates MMP-2 activity via NFkappaB-TIMP-2 pathway. Cell. Signal. 22: 212-220.
59. Choi, C., X. Xu, J. W. Oh, S. J. Lee, G. Y. Gillespie, H. Park, H. Jo, and E. N. Benveniste. 2001. Fas-induced expression of chemokines in human glioma cells: involvement of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase. Cancer Res. 61: 3084-3091.
60. Desbarats, J., R. B. Birge, M. Mimouni-Rongy, D. E. Weinstein, J. S. Palerme, and M. K. Newell. 2003. Fas engagement induces neurite growth through ERK activation and p35 upregulation. Nat. Cell Biol. 5: 118-125.
61. Chen, L., S. M. Park, A. V. Tumanov, A. Hau, K. Sawada, C. Feig, J. R. Turner, Y. X. Fu, I. L. Romero, E. Lengyel, and M. E. Peter. 2010. CD95 promotes tumour growth. Nature 465: 492-496.
62. Röder, C., A. Trauzold, and H. Kalthoff. 2010. Impact of death receptor signaling on the malignancy of pancreatic ductal adenocarcinoma. Eur. J. Cell Biol. 90: 450-455.